Clinical Trial

Digital BIOmarkers for the Assessment of Motor Status in Parkinson's Disease Patients with CLInical and ThErapeutic Application

Study acronym: BIOCLITE
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated February 20, 2025 (before its estimated April 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to define digital biomarkers of motor symptoms in Parkinson's disease patients using wearable devices. The main questions it aims to answer is: * Is there a biomarkers that allows the identification of PD from healthy controls? * Is there a biomarkers that can identify the severity of the disease? * Is there a biomarkers with clinical and therapeutic application that can be used in clinical and free living conditions to monitor the evolution of the disease? Participants have to perform a set of guided exercises related to the MDS-UPDRS guide and daily living tasks, in supervised and unsupervised conditions.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-04.
Trial Details
NCT Number NCT06817772
Lead Sponsor Universidad Politecnica de Madrid
Collaborators: Asociación Parkinson Madrid
Conditions Parkinson Disease, Parkinson
Enrollment 40 participants
Start Date 2024-12-09
Primary Completion 2025-04 (estimated)
Study Completion 2025-05 (estimated)
Updated on ClinicalTrials.gov 2025-02-20